CATIP
gene geneOn this page
Also known as MGC50811
Summary
CATIP (ciliogenesis associated TTC17 interacting protein, HGNC:25062) is a protein-coding gene on chromosome 2q35, encoding Ciliogenesis-associated TTC17-interacting protein (Q7Z7H3). Plays a role in primary ciliogenesis by modulating actin polymerization.
Involved in actin filament polymerization and cilium organization. Located in several cellular components, including actin cytoskeleton; nucleus; and plasma membrane. Implicated in spermatogenic failure 54.
Source: NCBI Gene 375307 — automated summary from GO annotations (Alliance of Genome Resources).
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 56 total — 1 likely-pathogenic
- GTEx eGene: eQTL in 10 tissues, sQTL in 2 (q < 0.05)
- Phenotypes (HPO): 17
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.14 (unconstrained)
- MANE Select transcript:
NM_198559 - Notable: 56 clinical variants but no curated precision-oncology (CIViC) evidence yet
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25062 |
| Approved symbol | CATIP |
| Name | ciliogenesis associated TTC17 interacting protein |
| Location | 2q35 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC50811 |
| Ensembl gene | ENSG00000158428 |
| Ensembl biotype | protein_coding |
| OMIM | 619387 |
| Entrez | 375307 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 7 protein_coding, 3 retained_intron, 2 protein_coding_CDS_not_defined
MANE Select: ENST00000289388
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1, TSL 2: 1, TSL 3: 3
ENST00000289388, ENST00000480532, ENST00000481940, ENST00000494447, ENST00000495773, ENST00000715906, ENST00000715907, ENST00000851693, ENST00000851694, ENST00000851695, ENST00000851696, ENST00001139129
RefSeq mRNA: 2 — MANE Select: NM_198559
NM_001320865, NM_198559
CCDS: CCDS2414
Canonical transcript exons
ENST00000289388 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001038842 | 218357534 | 218357734 |
| ENSE00001074994 | 218358037 | 218358092 |
| ENSE00001074995 | 218364628 | 218364752 |
| ENSE00001075001 | 218362735 | 218362902 |
| ENSE00001339360 | 218357095 | 218357187 |
| ENSE00001339369 | 218356857 | 218356909 |
| ENSE00001869443 | 218367722 | 218368094 |
| ENSE00003507596 | 218360573 | 218360659 |
| ENSE00003562236 | 218367430 | 218367518 |
| ENSE00003637600 | 218367024 | 218367100 |
Expression profiles
Bgee: expression breadth ubiquitous, 129 present calls, max score 95.62.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1955 / max 9.7597, expressed in 108 samples.
Highest expression (Bgee): uterine tube, olfactory segment of nasal mucosa, fallopian tube, lobe of thyroid gland, thyroid gland.
Genetic regulation across tissues (GTEx eQTL / sQTL)
CATIP is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 10 tissues and its splicing (sQTL) in 2 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
12 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Whole Blood | eqtl | 6.7e-22 | -0.38 | 2:218363885:C:T |
| Thyroid | eqtl | 9.6e-14 | -0.25 | 2:218357123:G:A |
| Testis | sqtl | 9.2e-11 | +0.60 | 2:218357123:G:A |
| Thyroid | sqtl | 1.9e-04 | +0.36 | 2:218357123:G:A |
| Spleen | eqtl | 1.6e-03 | -0.25 | 2:218343254:A:G |
| Brain Caudate basal ganglia | eqtl | 5.0e-03 | -0.18 | 2:218203057:C:T |
| Brain Anterior cingulate cortex BA24 | eqtl | 6.9e-03 | -0.77 | 2:218334281:T:C |
| Brain Putamen basal ganglia | eqtl | 1.1e-02 | +0.32 | 2:218356632:A:T |
| Testis | eqtl | 1.9e-02 | -0.24 | 2:217880754:G:T |
| Brain Cerebellum | eqtl | 2.8e-02 | +0.36 | 2:218356632:A:T |
| Pituitary | eqtl | 3.0e-02 | -0.21 | 2:219047907:A:G |
| Esophagus Gastroesophageal Junction | eqtl | 4.4e-02 | -0.85 | 2:217872547:T:C |
FANTOM5 promoters
2 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 25314 | 0.1482 | 84 |
| 25313 | 0.0472 | 23 |
Top tissues by expression
showing 100 of 134 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 95.62 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 87.63 | gold quality |
| fallopian tube | UBERON:0003889 | 80.48 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 76.80 | gold quality |
| thyroid gland | UBERON:0002046 | 75.82 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 75.39 | gold quality |
| blood | UBERON:0000178 | 74.90 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 74.73 | gold quality |
| monocyte | CL:0000576 | 74.35 | gold quality |
| right lung | UBERON:0002167 | 74.29 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 73.78 | gold quality |
| leukocyte | CL:0000738 | 73.74 | gold quality |
| left testis | UBERON:0004533 | 73.03 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 72.89 | gold quality |
| granulocyte | CL:0000094 | 72.83 | gold quality |
| testis | UBERON:0000473 | 72.67 | gold quality |
| right testis | UBERON:0004534 | 72.33 | gold quality |
| kidney | UBERON:0002113 | 70.82 | gold quality |
| metanephros cortex | UBERON:0010533 | 70.57 | gold quality |
| left uterine tube | UBERON:0001303 | 70.07 | gold quality |
| adenohypophysis | UBERON:0002196 | 69.95 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 68.38 | gold quality |
| pituitary gland | UBERON:0000007 | 68.37 | gold quality |
| cortex of kidney | UBERON:0001225 | 66.76 | gold quality |
| lung | UBERON:0002048 | 65.91 | gold quality |
| placenta | UBERON:0001987 | 65.39 | gold quality |
| prostate gland | UBERON:0002367 | 64.27 | gold quality |
| body of pancreas | UBERON:0001150 | 63.92 | gold quality |
| bone marrow | UBERON:0002371 | 63.64 | gold quality |
| bone marrow cell | CL:0002092 | 63.51 | silver quality |
| caudate nucleus | UBERON:0001873 | 63.05 | gold quality |
| hypothalamus | UBERON:0001898 | 62.48 | gold quality |
| endocervix | UBERON:0000458 | 62.28 | gold quality |
| spleen | UBERON:0002106 | 62.13 | gold quality |
| pancreas | UBERON:0001264 | 61.46 | gold quality |
| Ammon’s horn | UBERON:0001954 | 57.25 | gold quality |
| islet of Langerhans | UBERON:0000006 | 57.19 | gold quality |
| gall bladder | UBERON:0002110 | 57.19 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 57.09 | gold quality |
| left ovary | UBERON:0002119 | 57.08 | gold quality |
| temporal lobe | UBERON:0001871 | 56.43 | gold quality |
| left adrenal gland | UBERON:0001234 | 56.40 | gold quality |
| amygdala | UBERON:0001876 | 56.38 | gold quality |
| nucleus accumbens | UBERON:0001882 | 56.38 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 56.33 | gold quality |
| substantia nigra | UBERON:0002038 | 56.29 | gold quality |
| ovary | UBERON:0000992 | 56.28 | gold quality |
| myometrium | UBERON:0001296 | 56.23 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 55.80 | gold quality |
| right adrenal gland | UBERON:0001233 | 55.13 | gold quality |
| adrenal gland | UBERON:0002369 | 55.06 | gold quality |
| body of stomach | UBERON:0001161 | 54.73 | gold quality |
| right ovary | UBERON:0002118 | 54.44 | gold quality |
| body of uterus | UBERON:0009853 | 54.31 | gold quality |
| uterine cervix | UBERON:0000002 | 53.77 | gold quality |
| stomach | UBERON:0000945 | 53.30 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 52.86 | gold quality |
| liver | UBERON:0002107 | 52.84 | gold quality |
| right lobe of liver | UBERON:0001114 | 52.16 | gold quality |
| vermiform appendix | UBERON:0001154 | 52.02 | gold quality |
| material anatomical entity | UBERON:0000465 | 51.83 | gold quality |
| multicellular organism | UBERON:0000468 | 51.83 | gold quality |
| anatomical system | UBERON:0000467 | 51.80 | gold quality |
| fundus of stomach | UBERON:0001160 | 51.61 | gold quality |
| brain | UBERON:0000955 | 51.31 | gold quality |
| omental fat pad | UBERON:0010414 | 51.31 | gold quality |
| putamen | UBERON:0001874 | 51.25 | gold quality |
| endometrium | UBERON:0001295 | 50.53 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 50.22 | gold quality |
| adrenal tissue | UBERON:0018303 | 49.92 | gold quality |
| adipose tissue | UBERON:0001013 | 49.90 | gold quality |
| ectocervix | UBERON:0012249 | 49.90 | gold quality |
| apex of heart | UBERON:0002098 | 49.55 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 48.73 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 48.48 | gold quality |
| thoracic aorta | UBERON:0001515 | 48.40 | gold quality |
| urinary bladder | UBERON:0001255 | 48.18 | gold quality |
| ascending aorta | UBERON:0001496 | 48.15 | gold quality |
| left coronary artery | UBERON:0001626 | 47.85 | gold quality |
| tonsil | UBERON:0002372 | 47.54 | silver quality |
| anterior cingulate cortex | UBERON:0009835 | 47.28 | gold quality |
| right atrium auricular region | UBERON:0006631 | 47.09 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 46.79 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 46.75 | gold quality |
| cerebral cortex | UBERON:0000956 | 46.64 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 46.01 | gold quality |
| prefrontal cortex | UBERON:0000451 | 45.56 | gold quality |
| right coronary artery | UBERON:0001625 | 45.51 | gold quality |
| lymph node | UBERON:0000029 | 45.42 | gold quality |
| vagina | UBERON:0000996 | 45.26 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 45.07 | gold quality |
| frontal cortex | UBERON:0001870 | 44.93 | gold quality |
| lower esophagus | UBERON:0013473 | 44.72 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 44.68 | gold quality |
| heart | UBERON:0000948 | 44.58 | gold quality |
| right frontal lobe | UBERON:0002810 | 44.49 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 44.47 | silver quality |
| colon | UBERON:0001155 | 44.35 | gold quality |
| intestine | UBERON:0000160 | 44.07 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 43.88 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.32 |
HPA expression
RNA tissue specificity: Tissue enhanced
55 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM | Protein (IHC) |
|---|---|---|---|
| Fallopian tube | tissue | 18.9 | high |
| Choroid plexus | tissue | 11.6 | low |
| Periaqueductal gray | tissue | 10.2 | |
| Epididymis | tissue | 4.6 | not detected |
| Hypothalamus | tissue | 4.4 | |
| Septum | tissue | 4.2 | |
| Testis | tissue | 3.7 | low |
| Basal ganglia | tissue | 3.5 | not detected |
| Pons | tissue | 3.3 | |
| Hippocampal formation | tissue | 3.1 | |
| Superior colliculi | tissue | 2.8 | |
| Medulla oblongata | tissue | 2.7 | |
| Thalamus | tissue | 2.6 | |
| Cerebellum | tissue | 2.4 | not detected |
| Kidney | tissue | 2.3 | low |
| Parathyroid gland | tissue | 1.7 | not detected |
| Thyroid gland | tissue | 1.7 | not detected |
| Ventral forebrain | tissue | 1.7 | |
| Amygdala | tissue | 1.5 | |
| Lung | tissue | 1.5 | not detected |
| Olfactory bulb | tissue | 1.5 | |
| Midbrain | tissue | 1.4 | |
| Pituitary gland | tissue | 1.3 | |
| Corpus callosum | tissue | 1.2 | |
| Pancreas | tissue | 1.1 | not detected |
| Substantia nigra | tissue | 1.1 | |
| Seminal vesicle | tissue | 1.0 | not detected |
| Caudate putamen | tissue | 0.9 | |
| Placenta | tissue | 0.8 | not detected |
| Locus coeruleus | tissue | 0.8 | |
| Frontal cortex | tissue | 0.7 | |
| Nucleus accumbens | tissue | 0.7 | |
| Putamen | tissue | 0.6 | |
| Spinal cord | tissue | 0.6 | |
| Prostate | tissue | 0.6 | not detected |
| Entorhinal cortex | tissue | 0.6 | |
| Cervix | tissue | 0.5 | not detected |
| Prefrontal cortex | tissue | 0.5 | |
| Cerebral cortex | tissue | 0.5 | not detected |
| Retrosplenial cortex | tissue | 0.5 | |
| Temporal cortex | tissue | 0.5 | |
| Endometrium 1 | tissue | 0.4 | low |
| Hippocampus | tissue | 0.4 | not detected |
| Retrosplenial and cingulate cortex | tissue | 0.4 | |
| Occipital cortex | tissue | 0.4 | |
| Insular cortex | tissue | 0.4 | |
| Motor cortex | tissue | 0.3 | |
| Gallbladder | tissue | 0.3 | not detected |
| Somatosensory cortex | tissue | 0.3 | |
| Retina | tissue | 0.1 | |
| Spleen | tissue | 0.1 | not detected |
| Adrenal gland | tissue | 0.1 | medium |
| Bone marrow | tissue | 0.1 | not detected |
| Nasopharynx | tissue | -1.0 | medium |
| Bronchus | tissue | -1.0 | high |
Brain sub-regions (HPA Brain Atlas): detected in 187; highest nTPM — Periaquaductal grey, lateral (6.4), Nucleus tractus solitarii (5.0), Cervical spinal cord, central gray (4.7), Dorsal raphe nucleus (4.2), Periaquaductal grey, dorsal (4.1).
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
Targeting CATIP by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
2 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-296-5P | 97.61 | 64.02 | 851 |
| HSA-MIR-3189-5P | 97.55 | 66.71 | 655 |
Functional genomics
gnomAD constraint: pLI 2.43e-11, LOEUF 1.14, missense Z 0.261 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000289388 — one region, missense o/e 0.99.
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | catip | ENSDARG00000063009 |
| mus_musculus | Catip | ENSMUSG00000073650 |
| rattus_norvegicus | Catip | ENSRNOG00000037835 |
Paralogs (1): BAMBI (ENSG00000095739)
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:2685062) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 2 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| male infertility | 1 |
| increased mean platelet volume | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Xenopus laevis | Q0IHI3 | 50.8% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| MIR6810 | ncRNA | 102466197 |
| CATIP-AS2 | ncRNA | 103689911 |
| PNKD | protein-coding | 25953 |
| MIR26B | ncRNA | 407017 |
| CTDSP1 | protein-coding | 58190 |
| SLC11A1 | protein-coding | 6556 |
| CATIP-AS1 | ncRNA | 101928513 |
| MIR6513 | ncRNA | 102465256 |
| TMBIM1 | protein-coding | 64114 |
| USP37 | protein-coding | 57695 |
| VIL1 | protein-coding | 7429 |
| AAMP | protein-coding | 14 |
| GPBAR1 | protein-coding | 151306 |
Protein
Protein identifiers
Ciliogenesis-associated TTC17-interacting protein — Q7Z7H3 (reviewed: Q7Z7H3)
All UniProt accessions (2): A0ABB0MV25, Q7Z7H3
UniProt curated annotations — full annotation on UniProt →
Function. Plays a role in primary ciliogenesis by modulating actin polymerization.
Subunit / interactions. Interacts with TTC17.
Subcellular location. Nucleus. Cytoplasm. Cell membrane. Cytoskeleton.
Tissue specificity. Strongly expressed in round and elongating spermatids, weakly in pachytene spermatocytes. Expressed in Leydig cells (at protein level). Expressed in testis, placenta, prostate and lung, and moderately in ovary and brain.
Disease relevance. Spermatogenic failure 54 (SPGF54) [MIM:619379] An autosomal recessive male infertility disorder characterized by oligoteratoasthenozoospermia. Semen analysis shows markedly reduced sperm counts and severely reduced or absent sperm motility. The disease is caused by variants affecting the gene represented in this entry.
Similarity. Belongs to the CATIP family.
RefSeq proteins (2): NP_001307794, NP_940961* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR047501 | DD_CATIP | Domain |
| IPR048777 | CATIP_N | Domain |
Pfam: PF21772
UniProt features (6 total): region of interest 2, compositionally biased region 2, chain 1, sequence variant 1
Structure
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z7H3-F1 | 86.37 | 0.64 |
Human Protein Atlas
Protein class: Predicted intracellular proteins, Disease related genes, Human disease related genes
Protein evidence: Evidence at protein level
Subcellular location (HPA, imaging): connecting piece; mid piece
Antibody reliability (HPA): IH supported · IF approved
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
MSigDB gene sets: 64 (showing top):
GOBP_CILIUM_ORGANIZATION, GOBP_ACTIN_FILAMENT_ORGANIZATION, GOBP_CELL_PROJECTION_ORGANIZATION, KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3, SMAD4_Q6, GOBP_ACTIN_POLYMERIZATION_OR_DEPOLYMERIZATION, GOBP_PROTEIN_POLYMERIZATION, GOBP_SUPRAMOLECULAR_FIBER_ORGANIZATION, CCTNTMAGA_UNKNOWN, FOXJ2_TARGET_GENES, ZFP91_TARGET_GENES, HP_ABNORMALITY_OF_REPRODUCTIVE_SYSTEM_PHYSIOLOGY, HP_DECREASED_FERTILITY, HP_INFERTILITY, HP_OLIGOZOOSPERMIA
GO Biological Process (3): actin filament polymerization (GO:0030041), cilium organization (GO:0044782), cell projection organization (GO:0030030)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (5): nucleus (GO:0005634), cytoplasm (GO:0005737), plasma membrane (GO:0005886), actin cytoskeleton (GO:0015629), cytoskeleton (GO:0005856)
GO top-level categories
13 GO namespaces:
| Category | Terms |
|---|---|
| actin polymerization or depolymerization | 1 |
| protein polymerization | 1 |
| organelle organization | 1 |
| plasma membrane bounded cell projection organization | 1 |
| cellular component organization | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cytoskeleton | 1 |
| intracellular membraneless organelle | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 6 of 9 annotations. The rest are phylogenetic / computational / electronic (IEA).
6 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| actin filament polymerization | BP | direct assay |
| cilium organization | BP | mutant phenotype |
| actin cytoskeleton | CC | direct assay |
| cytoplasm | CC | direct assay |
| nucleus | CC | direct assay |
| plasma membrane | CC | direct assay |
Protein interactions and networks
STRING
showing 15 of 474 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CATIP | CTDSP1 | Q9GZU7 | 565 |
| CATIP | TPGS1 | Q6ZTW0 | 538 |
| CATIP | ROPN1 | Q9HAT0 | 512 |
| CATIP | CABYR | O75952 | 502 |
| CATIP | AK8 | Q96MA6 | 498 |
| CATIP | VWC2L | B2RUY7 | 490 |
| CATIP | FBXL13 | Q8NEE6 | 489 |
| CATIP | ROPN1B | Q9BZX4 | 485 |
| CATIP | ZFAND2B | Q8WV99 | 481 |
| CATIP | PCYT1B | Q9Y5K3 | 475 |
| CATIP | RNF25 | Q96BH1 | 468 |
| CATIP | TEX55 | Q96M34 | 459 |
| CATIP | ROPN1L | Q96C74 | 457 |
| CATIP | STK36 | Q9NRP7 | 449 |
| CATIP | TTLL4 | Q14679 | 439 |
IntAct
Human interaction partners of CATIP in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
16 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| KRT31 | physical association | 0.720 | 6 |
| BRD9 | physical association | 0.560 | 6 |
| CEP72 | physical association | 0.560 | 5 |
| CTNNBL1 | physical association | 0.560 | 3 |
| CYSRT1 | physical association | 0.560 | 3 |
| DDIT4L | physical association | 0.560 | 3 |
| GOLGA6L9 | physical association | 0.560 | 3 |
| HESX1 | physical association | 0.560 | 3 |
| KRT40 | physical association | 0.560 | 3 |
| KRTAP1-1 | physical association | 0.560 | 3 |
| KRTAP10-7 | physical association | 0.560 | 3 |
| KRTAP10-9 | physical association | 0.560 | 3 |
| MEDAG | physical association | 0.560 | 3 |
| MTUS2 | physical association | 0.560 | 3 |
| HNRNPA1L2 | physical association | 0.400 | 1 |
| ECE1 | physical association | 0.370 | 1 |
BioGRID (19 interactions; top human partners by supporting records): BRD9 (Two-hybrid; 2 records), KRT31 (Two-hybrid; 2 records), APP (Reconstituted Complex), CEP72 (Two-hybrid), CTNNBL1 (Two-hybrid), DDIT4L (Two-hybrid), GOLGA6L9 (Two-hybrid), HESX1 (Two-hybrid), HNRNPA1L2 (Affinity Capture-MS), KRT40 (Two-hybrid), KRTAP1-1 (Two-hybrid), KRTAP10-3 (Two-hybrid), KRTAP10-7 (Two-hybrid), KRTAP10-9 (Two-hybrid), MEDAG (Two-hybrid)
Disease & clinical
Genetic variants
Variant evidence for CATIP: 56 ClinVar records (1 pathogenic / likely pathogenic); 3 GWAS associations. Per-variant detail is on Sugi Variant.
ClinVar
56 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 1 |
| Uncertain significance | 50 |
| Likely benign | 4 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (1)
Showing all 1 pathogenic / likely-pathogenic ClinVar records, ranked by ClinVar review status (expert panel → multiple submitters → single submitter), then by number of submitting labs.
| Variant ID | HGVS | Classification | Review | Submitters |
|---|---|---|---|---|
| 1172755 | NM_198559.2(CATIP):c.103T>A (p.Phe35Ile) | Likely pathogenic | criteria provided, single submitter | 2 |
Per-variant reference — Sugi Variant
Explore CATIP’s pathogenic and likely-pathogenic variants individually — each with its ClinVar classification and conditions, applied ACMG criteria (ClinGen expert panel, where curated), the calibrated in-silico predictors (AlphaMissense, REVEL, SaProt, conservation), gnomAD frequency, and the predictor-disagreement QC signal — on Sugi Variant.
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 20 predictions of 1,046):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 2:218366570 | donor_gain | 1.0000 | |
| 2:218362899 | donor_gain | 0.9900 | |
| 2:218364615–218364616 | acceptor_gain | 0.9900 | 2 |
| 2:218364619 | acceptor_gain | 0.9900 | |
| 2:218364622 | acceptor_gain | 0.9900 | |
| 2:218364753–218364754 | donor_loss | 0.9900 | 6 |
| 2:218366550 | donor_gain | 0.9900 | |
| 2:218367094 | donor_gain | 0.9900 | |
| 2:218367428–218367429 | acceptor_loss | 0.9900 | 5 |
| 2:218367516 | donor_gain | 0.9900 |
AlphaMissense
378 missense substitutions predicted likely pathogenic (of 2,533 scored), across 142 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| F351 | 8 | 0.840 | 0.942 |
| F331 | 7 | 0.906 | 0.972 |
| R182 | 7 | 0.895 | 0.982 |
| F196 | 7 | 0.887 | 0.966 |
| W293 | 7 | 0.856 | 0.956 |
| F303 | 7 | 0.852 | 0.962 |
| D251 | 7 | 0.839 | 0.904 |
| F49 | 7 | 0.809 | 0.947 |
| D296 | 7 | 0.752 | 0.824 |
| D330 | 7 | 0.746 | 0.815 |
| G252 | 6 | 0.924 | 0.975 |
| M184 | 6 | 0.847 | 0.925 |
| F346 | 6 | 0.816 | 0.964 |
| H253 | 6 | 0.805 | 0.957 |
| P340 | 6 | 0.779 | 0.855 |
| D200 | 6 | 0.769 | 0.817 |
| F35 | 5 | 0.860 | 0.902 |
| E51 | 5 | 0.849 | 0.934 |
| F171 | 5 | 0.841 | 0.911 |
| G261 | 5 | 0.745 | 0.890 |
HPA cancer prognostics
RNA cancer specificity: Cancer enhanced (Kidney Renal Papillary Cell Carcinoma)
Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.
3 prognostic cancer types:
| Cancer | Prognostic | p-value |
|---|---|---|
| Kidney Renal Clear Cell Carcinoma (TCGA) | favorable | 3.97e-05 |
| Kidney Renal Papillary Cell Carcinoma (TCGA) | favorable | 5.74e-05 |
| Kidney Renal Clear Cell Carcinoma (validation) | favorable | 7.01e-05 |
Disease associations
OMIM: gene MIM:619387 | disease phenotypes: MIM:619379
GenCC curated gene-disease
Mondo (1): spermatogenic failure 54 (MONDO:0023664)
HPO phenotypes
17 phenotypes (HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000027 | Azoospermia |
| HP:0000118 | Phenotypic abnormality |
| HP:0000798 | Oligozoospermia |
| HP:0000837 | Increased circulating gonadotropin level |
| HP:0003251 | Male infertility |
| HP:0008669 | Abnormal spermatogenesis |
| HP:0008734 | Decreased testicular size |
| HP:0011462 | Young adult onset |
| HP:0011961 | Non-obstructive azoospermia |
| HP:0011962 | Obstructive azoospermia |
| HP:0012207 | Reduced sperm motility |
| HP:0030974 | Cryptozoospermia |
| HP:0032559 | Short sperm flagella |
| HP:0032560 | Coiled sperm flagella |
| HP:0032562 | Tapered sperm head |
| HP:0033524 | Abnormal sperm axoneme morphology |
GWAS associations
3 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST90020028_1079 | Hip circumference adjusted for BMI | 8e-12 |
| GCST90020028_1080 | Hip circumference adjusted for BMI | 9e-9 |
| GCST90020028_1077 | Hip circumference adjusted for BMI | 1e-8 |
EFO canonical traits (from GWAS)
1 canonical traits:
| EFO ID | Trait name |
|---|---|
| EFO:0008039 | BMI-adjusted hip circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | increases expression | 1 |
| dimethylselenide | increases expression, increases oxidation | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Ozone | increases oxidation, increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Hydroxyl Radical | increases expression, increases oxidation | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
12 trials:
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT03414970 | Phase 3 | ACTIVE_NOT_RECRUITING | Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer |
| NCT00461344 | Phase 2 | TERMINATED | Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer |
| NCT07499999 | Phase 2 | NOT_YET_RECRUITING | Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer |
| NCT00637364 | Phase 1/2 | SUSPENDED | High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer Pain |
| NCT02779855 | Phase 1/2 | COMPLETED | Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer |
| NCT01753908 | Early Phase 1 | COMPLETED | Broccoli Sprout Extract in Treating Patients With Breast Cancer |
| NCT01796041 | Early Phase 1 | COMPLETED | Intraoperative Imaging of Breast Cancer With Indocyanine Green |
| NCT07628634 | Early Phase 1 | RECRUITING | Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors |
| NCT01208974 | Not specified | COMPLETED | Nipple-Areola Complex (NAC) Irradiation After Nipple-Sparing Mastectomy and Reconstruction |
| NCT01875198 | Not specified | TERMINATED | Oncologic Impact of Splenectomy-omitting Radical Pancreatectomy in Well-selected Left-sided Pancreatic Cancer |
| NCT03543397 | Not specified | UNKNOWN | MRI in Ductal Carcinoma in Situ (DCIS) |
| NCT03834532 | Not specified | COMPLETED | Living Well After Breast Surgery |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): spermatogenic failure 54